TBCRC 022: Phase II trial of neratinib for patients (Pts) with human epidermal growth factor receptor 2 (HER2+) breast cancer and brain metastases (BCBM).
| Publication | Article in Journal of Clinical Oncology, published May 2014 |
|---|---|
| Authors | Rachel A. Freedman, Rebecca Sue Gelman, Jeffrey Scott Wefel, Ian E. Krop, Michelle E. Melisko,...[ show more ] |
This is the public page for a publication record in Dimensions, a free research insights platform that brings together information about funding, scholarly outputs, policy, patents and grants.
Loading metrics…